All FACS assays were performed in
96-well round bottom plates (Corning). For neutralization assays, cells were harvested by trypsinization. For cell surface staining, cells were harvested by scraping at the indicated time points and fixed in
4% PFA (Thermo Fisher Scientific). Surface bound virus and 9C12 was detected using anti-human IgG-AF568 (Thermo Fisher, 1:1000). FcγRs were detected using anti-CD64-FITC (10.1, eBioscience, 0.2μg/sample), anti-CD32-PE (6C4, eBioscience, 25 ng/sample) and anti-CD16-APC, eBioCB16, eBioscience, 12 ng/sample). After antibody incubation, cells were washed three times with PBS-FBS and resuspended in 100 μL PBS-FCS.
Samples were acquired on a
BD LSRII or a
BD LSRFortessa flow cytometer (BD Biosciences).
For staining of whole blood, red blood cells were lysed using
red blood cell lysis buffer (Miltenyi). After
Fc-block (93, eBioscience, 1:100) white blood cells were stained with α-CD3 (17A2, BioLegend, 2.5 μg/mL), α-CD8a (KT15, BioRad, 0.125 μg/mL), H-2K
b-SIINFEKL tetramer (MBL International, 2 μL/sample) and
viability dye (1:2500, eBioscience). Samples were acquired on an
iCyt Eclipse flow cytometer (Sony Biotechnology).
All flow cytometry data was analyzed using
FlowJo software (FlowJo, LLC).
Bottermann M., Foss S., Caddy S.L., Clift D., van Tienen L.M., Vaysburd M., Cruickshank J., O’Connell K., Clark J., Mayes K., Higginson K., Lode H.E., McAdam M.B., Sandlie I., Andersen J.T, & James L.C. (2019). Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host & Microbe, 25(4), 617-629.e7.